- Home
- CRNX vs AZZ Comparison
CRNX vs AZZ Comparison
Compare CRNX & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- AZZ
- Stock Information
- Founded
- CRNX 2008
- AZZ 1956
- Country
- CRNX United States
- AZZ United States
- Employees
- CRNX N/A
- AZZ N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- CRNX Health Care
- AZZ Industrials
- Exchange
- CRNX Nasdaq
- AZZ Nasdaq
- Market Cap
- CRNX 2.8B
- AZZ 3.0B
- IPO Year
- CRNX 2018
- AZZ N/A
- Fundamental
- Price
- CRNX $39.96
- AZZ $99.88
- Analyst Decision
- CRNX Buy
- AZZ Buy
- Analyst Count
- CRNX 12
- AZZ 7
- Target Price
- CRNX $74.45
- AZZ $115.43
- AVG Volume (30 Days)
- CRNX 1.2M
- AZZ 309.0K
- Earning Date
- CRNX 11-06-2025
- AZZ 10-08-2025
- Dividend Yield
- CRNX N/A
- AZZ 0.77%
- EPS Growth
- CRNX N/A
- AZZ 855.67
- EPS
- CRNX N/A
- AZZ 10.37
- Revenue
- CRNX $1,392,000.00
- AZZ $1,594,766,000.00
- Revenue This Year
- CRNX $405.68
- AZZ $5.28
- Revenue Next Year
- CRNX $1,034.87
- AZZ $5.12
- P/E Ratio
- CRNX N/A
- AZZ $9.99
- Revenue Growth
- CRNX 0.51
- AZZ 1.55
- 52 Week Low
- CRNX $24.10
- AZZ $70.90
- 52 Week High
- CRNX $62.53
- AZZ $119.95
- Technical
- Relative Strength Index (RSI)
- CRNX 44.22
- AZZ 44.66
- Support Level
- CRNX $41.41
- AZZ $98.14
- Resistance Level
- CRNX $43.89
- AZZ $104.27
- Average True Range (ATR)
- CRNX 1.94
- AZZ 2.98
- MACD
- CRNX -0.41
- AZZ 0.57
- Stochastic Oscillator
- CRNX 17.99
- AZZ 42.39
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.